Ignite Creation Date:
2024-05-06 @ 1:13 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01758263
Status:
UNKNOWN
Last Update Posted:
2013-01-01
First Post:
2012-12-26
Brief Title:
Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment
Sponsor:
Forest Laboratories
Organization:
Forest Laboratories
Study Overview
Official Title:
Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment A Retrospective Database Analysis
Status:
UNKNOWN
Status Verified Date:
2012-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a retrospective data analysis of patients with high blood pressure hypertension who took metoprolol for a minimum of 6 months who then switched to taking nebivolol for a minimum of 6 month to treat hypertension These patients will be identified from a large medical claims database This study tests the hypothesis alternative higher or lower that average patient monthly health care administrative cost changes after switching from metoprolol to nebivolol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None